Tobacco Class Action Attorney Jerome Block Featured in National Law Journal

The National Law Journal interviews LPK class action attorney Jerome H. Block in connection with the recently filed tobacco class action brought against Phillip Morris USA by long-time Marlboro cigarette smokers from New York.

Philip Morris USANEW YORK, New York, November 21, 2006 - In today's edition of The National Law Journal, Jerome H. Block, a class action attorney and partner at Levy Phillips and Konigsberg, LLP, discussed the merits of a potentially pathfinding tobacco lawsuit that the law firm has launched against Phillip Morris USA. The tobacco class action, which seeks medical monitoring for people over the age of fifty, who have smoked at least a pack-a-day of Marlboro cigarettes, has generated a significant amount of attention in the media and in legal circles.

"The sole relief we are seeking is that Phillip Morris pay for a program of CT Scans," said Block in The National Law Journal article1. A study that was recently published in The New England Journal of Medicine2 provides further confirmation that Low Dose CT Scans of the chest ("LDCT") constitute an enormously powerful tool to help doctors detect lung cancer in its early stages of development thereby increasing survival rates and saving lives.

Lung cancer causes more than 160,000 deaths each year in the United States. LDCT screening offers hope for millions of Americans who are at increased risk of developing lung cancer from cigarette smoking.

Unfortunately, when employed as an early cancer screening device, LDCT is not usually covered by most medical insurers. Thus, as Block noted in the article, "This is for all those people out there who don't have this covered and are at increased risk of lung cancer. It's a huge issue from a public health point of view."

For more information about the benefits of CT scans for the early detection of lung cancer, go to www.ielcap.org.

1 "Smokers Sue Tobacco Company for Lung Scans" (The National Law Journal, 11/21/2006);
2 "Survival of Patients with Stage I Lung Cancer Detected on CT Screening" (The New England Journal of Medicine, 10/26/2006).

[ Top of page ]

Share
 

DO YOU HAVE A CASE? FIND OUT NOW!

Your Name (*) Please let us know your name
Your Phone Number Invalid Input
Your Email Address (*) Please let us know your email address
Type of Case Invalid Input
About the Case (*) Please provide us with case details
Verify the anti-spam code: Verify the anti-spam code:
Invalid code. Please, try again.

NEW YORK OFFICES

new york city800 Third Avenue, 11th Floor
New York, New York 10022
Telephone: 212.605.6200
goshen new york42 Park Place
Goshen, New York 10924
Telephone: 845.294.2002

NEW JERSEY OFFICE

new jersey101 Grovers Mill Rd, Ste 105
Lawrence, New Jersey 08648
Telephone: 609.720.0400

CALIFORNIA OFFICE

los angeles10990 Wilshire Blvd, Ste 1025
Los Angeles, California 90024
Telephone: 800.988.8005

CONNECT WITH US ON FACEBOOK

VOTE FOR OUR WEBSITE ON GOOGLE

  If you like our website, let Google know about it by pressing the +1 button. Thank you!
We have 159 guests online